Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex

被引:83
作者
Soto, U
Das, BC
Lengert, M
Finzer, P
zur Hausen, H
Rösl, F
机构
[1] Deutsch Krebsforschungszentrum, Forsch Schwerpunkt Angew Tumorvirol, D-69120 Heidelberg, Germany
[2] Maulana Azad Med Coll, Inst Cytol & Prevent Oncol, Div Mol Oncol, New Delhi, India
关键词
human papillomavirus; cervical cancer; AP-1; negative regulation; cytokines;
D O I
10.1038/sj.onc.1202765
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AP-1 represents a transcription factor, which plays a pivotal role in initiating and maintaining the expression of human papillomavirus (HPV) oncoproteins E6 and E7 during HPV-linked carcinogenesis of the uterine cervix. AP-1 stands as a synonym for different proteins such as c-Jun, JunB, JunD, c-Fos, FosB as well as the Fos-related antigens Fra-1 and Fra-2, which can either homo- or heterodimerize to build up a functional transcription complex, AP-1 is mainly considered as a positive regulator, which binds to cognate DNA sequences within the viral upstream regulatory region, By using nontumorigenic HeLa-fibroblast hybrids ('444'), their tumorigenic segregants ('CGL3') as well as HPV 18 positive HeLa cells as a experimental model system, evidence is provided that AP-1 composition differs considerably between these cell lines, In nuclear extracts obtained from non-tumorigenic cells, Jun-family members (in the order c-Jun > JunD > JunB) were mainly heterodimerized with Fra-1, a protein, known to be involved in the abrogation of AP-1 activity under certain experimental conditions, In contrast, Fra-1 concentration is low in extracts from tumorigenic cells, Conversely, c-Fos, the canonical dimerization partner of Jun proteins is expressed in substantial quantity in HeLa- and 'CGL3' cells, but it is completely absent in AP-1 complexes from non-tumorigenic '444' cells, Ectopical expression of c-fos under a heterologous promoter in '444'-cells induces tumorigenicity and a change of the Jun/Fra-1 ratio towards a constellation initially detected in 'CGL3'-and HeLa cells. Furthermore, conversion to tumorigenicity is accompanied with a resistance against TNF-alpha, a cytokine, capable to selectively suppress HPV 18 transcription in formerly non-malignant cells, These data propose a novel role for AP-1 as an essential component of an inter- and intracellular surveillance mechanism negatively controlling HPV transcription in non-tumorigenic cells.
引用
收藏
页码:3187 / 3198
页数:12
相关论文
共 81 条
[1]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[2]   The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors [J].
Antinore, MJ ;
Birrer, MJ ;
Patel, D ;
Nader, L ;
McCance, DJ .
EMBO JOURNAL, 1996, 15 (08) :1950-1960
[3]   Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro [J].
Arts, J ;
Herr, I ;
Lansink, M ;
Angel, P ;
Kooistra, T .
NUCLEIC ACIDS RESEARCH, 1997, 25 (02) :311-317
[4]  
ATTIA MAM, 1966, CANCER RES, V26, P1787
[5]   RETINOIC ACID-MEDIATED REPRESSION OF HUMAN PAPILLOMAVIRUS-18 TRANSCRIPTION AND DIFFERENT LIGAND REGULATION OF THE RETINOIC ACID RECEPTOR BETA-GENE IN NONTUMORIGENIC AND TUMORIGENIC HELA HYBRID-CELLS [J].
BARTSCH, D ;
BOYE, B ;
BAUST, C ;
HAUSEN, HZ ;
SCHWARZ, E .
EMBO JOURNAL, 1992, 11 (06) :2283-2291
[6]  
BERGERS G, 1995, MOL CELL BIOL, V15, P3748
[7]   SUPPRESSION INVIVO OF HUMAN PAPILLOMAVIRUS TYPE-18 E6-E7 GENE-EXPRESSION IN NONTUMORIGENIC HELAXFIBROBLAST HYBRID-CELLS [J].
BOSCH, FX ;
SCHWARZ, E ;
BOUKAMP, P ;
FUSENIG, NE ;
BARTSCH, D ;
ZURHAUSEN, H .
JOURNAL OF VIROLOGY, 1990, 64 (10) :4743-4754
[8]   A NEW TYPE OF PAPILLOMAVIRUS DNA, ITS PRESENCE IN GENITAL CANCER BIOPSIES AND IN CELL-LINES DERIVED FROM CERVICAL-CANCER [J].
BOSHART, M ;
GISSMANN, L ;
IKENBERG, H ;
KLEINHEINZ, A ;
SCHEURLEN, W ;
HAUSEN, HZ .
EMBO JOURNAL, 1984, 3 (05) :1151-1157
[9]   TRANSCRIPTIONAL CONTROL OF HUMAN PAPILLOMAVIRUS (HPV) ONCOGENE EXPRESSION - COMPOSITION OF THE HPV TYPE-18 UPSTREAM REGULATORY REGION [J].
BUTZ, K ;
HOPPESEYLER, F .
JOURNAL OF VIROLOGY, 1993, 67 (11) :6476-6486
[10]   INDUCTION OF C-FOS EXPRESSION THROUGH JNK-MEDIATED TCF/ELK-1 PHOSPHORYLATION [J].
CAVIGELLI, M ;
DOLFI, F ;
CLARET, FX ;
KARIN, M .
EMBO JOURNAL, 1995, 14 (23) :5957-5964